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A permissive function of phosphoinositide 3-kinase in Ras
activation mediated by inhibition of GTPase-activating proteins
Ignacio Rubio and Reinhard Wetzker
The activation status of the guanosine triphosphate
(GTP)-binding protein Ras is dictated by the relative
intensities of two opposing reactions: the  formation of
active Ras–GTP complexes, promoted by guanine-
nucleotide exchange factors (GEFs), and their
conversion to inactive Ras–GDP as a result of the
deactivating action of GTPase-activating proteins
(GAPs). The relevance of phosphoinositide 3-kinase
(PI 3-kinase) to these processes is still unclear. We
have investigated the regulation of Ras activation by
PI 3-kinase in the myelomonocytic U937 cell line. These
cells exhibited basal levels of Ras—GTP, which were
suppressed by two PI 3-kinase inhibitors and a
dominant-negative PI 3-kinase. In addition, PI 3-kinase
inhibition aborted Ras activation by all stimuli tested,
including foetal calf serum (FCS) and phorbol
12-myristate 13-acetate (TPA). Significantly, TPA does
not activate PI 3-kinase in U937 cells, indicating that
PI 3-kinase has a permissive rather than an intermediary
role in Ras activation. Investigation of the mechanism of
PI 3-kinase action revealed that inhibition of PI 3-kinase
does not affect nucleotide exchange on Ras but
abrogates Ras–GTP accumulation through an increase
in GAP activity. These findings establish blockage of
GAP action as the mechanism underlying a permissive
function of PI 3-kinase in Ras activation.
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Results and discussion
To study Ras activation in myelomonocytic U937 cells we
used the Ras-binding domain (RBD) pullout method [1].
As shown in Figure 1a, serum-starved U937 cells rapidly
accumulate Ras–GTP upon stimulation with FCS. The
two immunoreactive bands correspond to K-Ras and N-Ras
(collectively referred to as Ras from here on; data not
shown). Unstimulated cells reproducibly exhibited consti-
tutive levels of Ras–GTP accounting for 3–5% of total Ras
[2–4]. In the course of these experiments we obtained evi-
dence of high nucleotide-exchange activity and GAP
activity in U937 cells (see Supplementary material). To
verify these indications, we investigated the nucleotide-
exchange and GAP reactions in vivo. We perfused strep-
tolysin O (SLO)-permeabilised U937 cells with [α32P]GTP
and followed the radioactivity associated with Ras in
immunoprecipitations (IPs). Nucleotide uptake by Ras
saturated after 2–3 minutes (Figure 1b) and was too fast to
be due to the intrinsic nucleotide-exchange rate of Ras
[2]. The signal was chased by excess cold GTP and was
fully dependent on the presence of SLO and the Ras-spe-
cific immunoprecipitating antibody Y13-259 (Figure 1b,
and data not shown). This result confirms the presence of
active GEFs for Ras in resting U937 cells and is reminis-
cent of previous findings in unstimulated T cells [2]. To
test Ras-GAP activity in vivo, we loaded permeabilised
cells with recombinant, post-translationally unmodified
[α32P]GTP–Ha-Ras. Whereas [α32P]GTP bound to wild-
type Ha-Ras was rapidly converted to [α32P]GDP upon
entrance into the cells, the GAP-insensitive, GTPase-defi-
cient V12A38 Ha-Ras mutant [5] remained in the GTP-
bound form (Figure 1c). These results demonstrate the
existence of high cytosolic Ras-GAP activity in resting
U937 cells. From these findings we conclude that Ras
undergoes highly dynamic GDP–GTP cycling in resting
U937 cells.
To test the possible participation of PI 3-kinases in the
regulation of the Ras GDP–GTP cycle, we investigated
the effect of various inhibitors on basal Ras–GTP accumu-
lation. The two PI 3-kinase inhibitors wortmannin and
LY294002 totally abrogated basal Ras–GTP formation
(Figure 2a). The tyrosine kinase (TK) inhibitor genistein
also blocked Ras–GTP generation, whereas the wide-
spectrum protein kinase inhibitor staurosporine reduced
the signal by 70–80%. Inhibitors for MEK (PD98059) and
PKC (bisindolylmaleimide IX), and the calcium ionophore
ionomycin showed no effect. These results implicate PI
3-kinases and TKs in the control of the Ras GDP–GTP
cycle in resting U937 cells. We next addressed the ques-
tion of whether inhibition of basal Ras–GTP accumulation
would preclude Ras activation by extracellular stimuli.
Figure 2b shows that the two PI 3-kinase inhibitors
blocked Ras–GTP accumulation induced by insulin, ATP,
phorbol 12-myristate 13-acetate (TPA) and FCS. In con-
trast, genistein suppressed Ras activation by insulin, FCS
and TPA, but did not prevent the ATP-dependent
increase in Ras–GTP. Similarly, the two PKC inhibitors
bisindolylmaleimide I and IX blocked Ras activation
induced by TPA, but not that induced by ATP, FCS or
insulin [3,6,7]. In conclusion, the two PI 3-kinase inhibitors
were the only drugs that totally suppressed levels of basal
Ras–GTP and Ras–GTP induced by all the stimuli
tested. In this respect, the inhibition of TPA-induced
Ras–GTP accumulation by wortmannin and LY294002 is
of special significance, as it is well established that TPA
does not activate PI 3-kinase in U937 and other myeloid-
derived cells [8,9]. From these results we conclude that
the role of PI 3-kinase in the control of Ras activation is
permissive in nature.
Accumulation of cellular Ras–GTP depends on nucleotide
exchange on Ras, catalysed by GEFs, and hydrolysis of
Ras-bound GTP, which is mediated by GAP proteins. To
determine which of these two reactions was regulated by
PI 3-kinase, we analysed nucleotide exchange on Ras in
inhibitor-treated cells. As shown in Figure 3a, neither of
the two PI 3-kinase inhibitors reduced the initial rate
of [α32P]nucleotide uptake by Ras. In fact, nucleotide
uptake by Ras in control- and wortmannin-treated cells
was virtually indistinguishable, indicating that PI 3-kinase
is not necessary for nucleotide exchange on Ras in resting
cells. Evaluation of Ras-bound [α32P]nucleotides by thin
layer chromatography (TLC) confirmed that wortmannin
treatment had abrogated Ras–GTP accumulation without
affecting nucleotide uptake by Ras (Figure 3b). Quantifi-
cation of the GDP/GTP signals at steady state revealed
3–4% GTP/(GDP + GTP) in untreated and 0.3–0.7%
GTP/(GDP + GTP) in wortmannin-treated cells. In
marked contrast to the PI 3-kinase inhibitors, genistein
and staurosporine blocked nucleotide exchange on Ras
(Figure 3a,b).
We recapitulated these findings by combining the perme-
abilisation protocol with the RBD pullout assay. We rea-
soned that the non-hydrolysable GTP analogue GTP-γ-S
should drive Ras activation via uptake of GTP-γ-S by Ras
independently of the presence of high GAP activity. As
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Figure 1
Ras–GTP formation in U937 cells. (a) Basal
and FCS-induced Ras–GTP levels in U937
cells. Serum-starved U937 cells were treated
as indicated, and accumulation of Ras–GTP
was assayed by the RBD pullout assay. The
locations of K-Ras and N-Ras are indicated.
The lane labelled Load is a load control with
1% of the U937 cell lysate used in each
point. (b) In vivo nucleotide exchange on Ras
in resting U937 cells. Cells were
permeabilised at 37°C in the presence (open
circles) or absence (open squares) of
streptolysin O (SLO) and loaded with
[α32P]GTP. A separate experiment in the
presence of SLO included a chase with
100 µM GTP at 3 min (open triangles).
Nucleotide uptake by Ras was determined as
described in Supplementary material.
(c) Cytosolic Ras-GAP activity in resting
U937 cells. Cells were permeabilised with
SLO or mock treated with permeabilisation
buffer lacking SLO and loaded with 60 nM
(final concentration) of the indicated,
unprocessed [α32P]GTP-labelled Ha-Ras
(0.3 µCi/µM) species. After
immunoprecipitation at various time points,
Ras-bound nucleotides were eluted and
resolved by thin layer chromatography.
Three independent experiments yielded
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Figure 1
Pharmacological characterisation of constitutive and agonist-induced
Ras–GTP accumulation. (a) Sensitivity to inhibitors of Ras–GTP
formation in resting U937 cells. Serum-starved U937 cells were
treated for 10 min with the indicated inhibitors and subjected to a RBD
pullout assay. The panel includes a control stimulation with 10% FCS
for 1 min. (b) Inhibitor sensitivity of agonist-induced Ras activation.
Serum-starved cells were treated for 10 min with different inhibitors
and challenged with various agonists or stimuli as indicated. bis.I/IX,
bisindolylmaleimide I/IX.
(b)
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expected, cells permeabilised in the absence of GTP-γ-S
exhibited wortmannin- and genistein-sensitive basal
Ras–GTP levels (Figure 3c). In contrast, GTP-γ-S loading
resulted in accumulation of active Ras in control and wort-
mannin-treated cells but not in cells treated with genis-
tein. Although GTP-γ-S is likely to activate a number of
cellular GTPases in this experiment, the result is never-
theless consistent with the notion that PI 3-kinase is not
required for nucleotide exchange on Ras. We conclude
from all these data that PI 3-kinase inhibits GAP action to
allow formation of Ras–GTP.
The coincidence of effects elicited by wortmannin and
LY294002, as observed throughout our experiments, is
generally accepted as a solid criterion for the involvement
of PI 3-kinase in biological processes. Moreover, dose-
response experiments with these inhibitors strongly impli-
cated PI 3-kinase in the control of basal Ras–GTP
generation (see Supplementary material). Nevertheless, to
exclude an artefactual reaction of the PI 3-kinase
inhibitors, we tested the effect of a dominant-negative PI
3-kinase on basal Ras–GTP formation. Addition of the
kinase-dead p85α/K802R-p110α PI 3-kinase heterodimer
[10] to permeabilised resting U937 cells resulted in a rapid
drop of Ras-bound [α32P]GTP, whereas treatment with
wild-type p85α/p110α was without effect (Figure 3d, left
panel, and 3e). Interestingly, the adaptor subunit p85α on
its own was less effective in suppressing Ras–GTP accumu-
lation than the p85α/K802R-p110α complex (Figure 3d,
right panel, and 3e), which suggested an important input at
the level of the p110α subunit. Thus, the inhibitory effect
of the kinase-dead PI 3-kinase on Ras–GTP accumulation
consolidates the inhibitor data. Furthermore, the fact that
wild-type PI 3-kinase did not increase Ras–GTP levels
indicates that PI 3-kinase is not rate-limiting for Ras–GTP
accumulation in resting U937 cells.
Taken together, our findings demonstrate bimodal regula-
tion of Ras activity in resting U937 cells (Figure 4). In
addition to the established stimulation of GEFs mediated
by TKs, suppression of Ras-GAP action by PI 3-kinase is
essential for accumulation of Ras–GTP. Our data provide
strong evidence for a permissive role of PI 3-kinase in this
process. This scenario provides an explanation for recent
findings on a lack of stimulation of Ras or the ERK/Ras
effector pathway by activated versions of PI 3-kinase
[11–13]. These findings contradicted studies reporting a
role of PI 3-kinase upstream of Ras [12,14], but can now
be reconciled by assuming a permissive function of PI
3-kinase in Ras activation. In particular, the non-rate-lim-
iting nature of this PI 3-kinase function can explain the
ineffectiveness of constitutively active PI 3-kinases in pro-
moting Ras/ERK activation [11,12]. Furthermore, GAP
inhibition by PI 3-kinase may underlie recent findings on
the sensitivity to wortmannin or LY294002 of Ras activa-
tion by low doses of extracellular agonists [12]. We have
not been able to overcome the PI 3-kinase inhibitor block
with high doses of agonists (Figure 2b, and data not shown),
Brief Communication 1227
Figure 3
The role of PI 3-kinase and TKs in the
regulation of the Ras GDP–GTP cycle
in resting U937 cells. (a) Uptake of
α32P-labelled nucleotide by Ras in resting,
inhibitor-treated U937 cells. Before
[α32P]GTP loading at 37°C, cells were
treated 5 min with 100 nM wortmannin (filled
squares), 50 µM LY294002 (open circles),
100 µM genistein (filled circles) or 1 µM
staurosporine (open triangles). Open squares
indicate the untreated control. Nucleotide
uptake was determined as described for
Figure 1b (see also Supplementary material).
Similar results were obtained in four
independent experiments. (b) TLC analysis of
Ras-bound α32P-labelled nucleotides in
inhibitor-treated, resting cells. Cells were
treated and processed as in (a), followed by
elution and TLC analysis of Ras-bound
nucleotides. Three independent experiments
yielded similar results. W, wortmannin;
G, genistein. (c) Sensitivity of GTP-γ-S uptake
by Ras to inhibitors, in permeabilised U937
cells. Cells were incubated with the indicated
inhibitors or the vehicle DMSO (conditions as
in (a)) and permeabilised in the absence or
presence of 1 mM GTP-γ-S. Cell lysates were
prepared 0, 1 and 3 min after
permeabilisation and subjected to RBD
pullout assays. (d) Dominant-negative PI
3-kinase blocks Ras–GTP accumulation.
Serum-starved U937 cells were
permeabilised at 30°C and processed as in
(b). At 3.25 min, 200 nM (final concentration)
of various PI 3-kinase species or an
equivalent volume of vehicle were added to
the permeabilised cells. Two independent
sets of experiments yielded virtually identical
results. (e) Quantification of GTP levels from
(d). GTP levels from control cells at 5–6 min
(steady-state) were pooled and taken as
100%. Filled squares, untreated control; open
triangles, p85α/p110α; open circles,
p85α/K802R-p110α; open squares, p85α.
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in contrast to results in COS cells [12]. This failure may be
related to the particularly high level of GAP activity in
U937 cells. If this explanation turns out to be valid, the
impact of GAP inhibition by PI 3-kinase on Ras activation
may vary among cell types, depending on  different cell-
specific properties that affect the magnitude and agonist
sensitivity of Ras–GTP accumulation.
The increase in GAP activity induced by PI 3-kinase
inhibitors indicates that resting levels of the lipids pro-
duced in the plasma membrane by PI 3-kinase inhibit the
action of GAP proteins on Ras. We found that wortmannin
pretreatment of U937 cells did not alter GAP activity as
assayed from cell lysates (data not shown). This suggests
that membrane integrity is important for PI3-kinase-medi-
ated inhibition of GAPs. Considering that Ras can activate
PI 3-kinase through a direct interaction with the p110 cat-
alytic subunit [15], our data suggest the following scenario.
Active Ras could activate PI 3-kinase to induce spatially
restricted generation of 3-phosphoinositides. This would
promote local downregulation of relevant GAP species
and thus allow basal Ras activation.
Supplementary material
Supplementary material including the results of PI 3-kinase inhibitor
dose–response experiments, and RBD pullout assays confirming high
GEF and GAP activity in resting U937 cells, as well as detailed method-
ology is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Schematic view of the role of PI 3-kinase and TK in the regulation of
the Ras GDP–GTP cycle in resting U937 cells. The scheme includes
the points of entry of relevant inhibitors.
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